NYSE:CTST - CannTrust Stock Price, Forecast & News

CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."

CannTrust is scheduled to release their next quarterly earnings announcement on Wednesday, December 18th 2019. View Earnings Estimates for CannTrust.

8 brokers have issued 12 month price targets for CannTrust's stock. Their forecasts range from C$2.00 to C$7.00. On average, they expect CannTrust's share price to reach C$4.50 in the next twelve months. This suggests a possible upside of 435.7% from the stock's current price. View Analyst Price Targets for CannTrust.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CannTrust.

News coverage about CTST stock has trended extremely negative recently, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. CannTrust earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for CannTrust.

CannTrust saw a decline in short interest during the month of November. As of November 29th, there was short interest totalling 13,120,000 shares, a decline of 8.6% from the November 14th total of 14,350,000 shares. Based on an average trading volume of 2,340,000 shares, the short-interest ratio is currently 5.6 days. Approximately 11.0% of the company's shares are short sold. View CannTrust's Current Options Chain.

Some companies that are related to CannTrust include MacroGenics (MGNX), Emisphere Technologies (EMIS), Prothena (PRTA), Stemline Therapeutics (STML), Crinetics Pharmaceuticals (CRNX), ProQR Therapeutics (PRQR), Morphic (MORF), Akorn (AKRX), Organogenesis (ORGO), Sinovac Biotech (SVA), Ardelyx (ARDX), DiaMedica Therapeutics (DMCAF), Catalyst Pharmaceuticals (CPRX), Aptorum Group (APM) and Assembly Biosciences (ASMB).

Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Aurora Cannabis (ACB), Cronos Group (CRON), HEXO (HEXO), Nokia Oyj (NOK), Aphria (APHA) and OrganiGram (OGI).

CannTrust's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Legacy Advisors LLC (0.04%), Cambridge Investment Research Advisors Inc. (0.03%) and Virtu Financial LLC (0.02%). Company insiders that own CannTrust stock include Aubrey Dan, Financial Corporation Forum and Mark Litwin. View Institutional Ownership Trends for CannTrust.

CTST stock was sold by a variety of institutional investors in the last quarter, including Legacy Advisors LLC. View Insider Buying and Selling for CannTrust.

CTST stock was bought by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc. and Virtu Financial LLC. View Insider Buying and Selling for CannTrust.

Shares of CTST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTST stock can currently be purchased for approximately C$0.84.

CannTrust has a market capitalization of C$118.85 million and generates C$35.22 million in revenue each year. The company earns C$-10,460,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. CannTrust employs 576 workers across the globe.View Additional Information About CannTrust.

The official website for CannTrust is http://www.canntrust.ca/.

CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected]